Epidemiology and treatment of psoriasis: a Brazilian perspective

Código QR

Epidemiology and treatment of psoriasis: a Brazilian perspective

Gleison V Duarte,1 Larissa Porto-Silva,2 Maria de Fátima Paim de Oliveira1 1Dermatology Department, Federal University of Bahia, Salvador, 2Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil Abstract: Psoriasis is a chronic immune-mediated systemic dis...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Duarte GV, Porto-Silva L, Oliveira MdeFP
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Dermatology RL1-803
Acceso en línea:	https://doaj.org/article/ef1be92f0b0c4a46905ffc76e59edf23
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Epidemiology and treatment of psoriasis: a Chinese perspective
por: Pan R, et al.
Publicado: (2014)

Psoriasis: epidemiology, natural history, and differential diagnosis
por: Basko-Plluska JL, et al.
Publicado: (2012)

Psoriasis and cardiovascular disease: epidemiology, mechanisms, and clinical implications
por: Pearson KC, et al.
Publicado: (2012)

Pustular psoriasis: pathophysiology and current treatment perspectives
por: Benjegerdes KE, et al.
Publicado: (2016)

Emerging treatment options for psoriasis
por: Taheri A, et al.
Publicado: (2014)

Biomarkers in the pathogenesis, diagnosis, and treatment of psoriasis
por: Molteni S, et al.
Publicado: (2012)

The management of psoriasis through diet
por: Duarte G, et al.
Publicado: (2012)

Long-term safety of biologics in the treatment of psoriasis
por: Panchal MR, et al.
Publicado: (2013)

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence
por: Yélamos O, et al.
Publicado: (2015)

Psoriasis in childhood: effective strategies to improve treatment adherence
por: Shah KN, et al.
Publicado: (2015)

Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
por: Levy LL, et al.
Publicado: (2012)

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
por: Nicolazzo D, et al.
Publicado: (2014)

Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability
por: Rogalski C
Publicado: (2015)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer S, et al.
Publicado: (2015)

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik B, et al.
Publicado: (2016)

Psoriasis and sexual dysfunction: links, risks, and management challenges
por: Duarte GV, et al.
Publicado: (2018)

Psoriasis in pregnancy: challenges and solutions
por: Vena GA, et al.
Publicado: (2015)

Self-management in patients with psoriasis
por: Pathak SN, et al.
Publicado: (2014)

Lipid profile in psoriasis patients
por: Bhat RM, et al.
Publicado: (2012)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
por: Chiricozzi A, et al.
Publicado: (2019)

Fumaric acid esters in the management of psoriasis
por: Balak DMW
Publicado: (2015)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh RK, et al.
Publicado: (2016)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo Y, et al.
Publicado: (2021)

Plaque psoriasis in children and adolescents &ndash; the role of etanercept
por: Ricceri F, et al.
Publicado: (2012)

Optimal management of nail disease in patients with psoriasis
por: Piraccini BM, et al.
Publicado: (2015)

Links and risks associated with psoriasis and metabolic syndrome
por: Liakou AI, et al.
Publicado: (2015)

Quality of life issues and measurement in patients with psoriasis
por: Tan X, et al.
Publicado: (2012)

Role of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapy
por: Flatz L, et al.
Publicado: (2013)

Clinical potential of brodalumab in the management of psoriasis: the evidence to date
por: Sandoval LF, et al.
Publicado: (2015)

Management of guttate psoriasis in patients with associated streptococcal infection
por: Karabudak Abuaf O, et al.
Publicado: (2012)

Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
por: Hanna Niehues, et al.
Publicado: (2022)

CD8αα+T cells exert a pro‐inflammatory role in patients with psoriasis
por: Y. Y. Zhang, et al.
Publicado: (2021)

Emerging Roles of Adipose Tissue in the Pathogenesis of Psoriasis and Atopic Dermatitis in Obesity
por: Zhuolin Guo, et al.
Publicado: (2022)

The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis
por: M. Panahi, et al.
Publicado: (2021)

Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability
por: Manalo IF, et al.
Publicado: (2015)

Safety profiles of topical vitamin D3 in psoriasis patients: a retrospective large-scale study
por: Yamamoto A, et al.
Publicado: (2012)

Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study
por: Narayanan S, et al.
Publicado: (2014)

Reanalysis of microarray data reveals insights into altered transcriptional activity of T helper 17 and regulatory T cell signaling in psoriasis
por: Kotb I, et al.
Publicado: (2013)

Epidemiology, genetics and management of psoriatic arthritis 2013: focus on developments of who develops the disease, its clinical features, and emerging treatment options
por: Haroon M, et al.
Publicado: (2013)

Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
por: S. K. Henne, et al.
Publicado: (2021)